8.3.4: Hormone Antagonists

Part of chapter 8 Malignant Disease & Immunosuppression, section 8.3 Sex Hormones & Antag In Malig Disease


High-level prescribing trends for Hormone Antagonists (BNF section 8.3.4) across all GP practices in NHS England for the last five years. You can explore prescribing trends for this section by CCG, or learn more about this site.

No prescriptions found.

Do you need help with your analysis? We can provide custom extracts from our prescribing data for free. to find out more.

Chemicals

Abiraterone (0803042T0)
Anastrozole (0803041B0)
Bicalutamide (0803042A0)
Buserelin (0803042B0)
Cyproterone Acetate (0803042E0)
Degarelix (0803042R0)
Enzalutamide (0803042U0)
Exemestane (0803041C0)
Flutamide (0803042H0)
Fulvestrant (0803041AA)
Goserelin Acetate (0803042K0)
Histrelin Acetate (0803042Q0)
Lanreotide (0803043P0)
Letrozole (0803041L0)
Leuprorelin Acetate (0803042N0)
Octreotide Acetate (0803043N0)
Pasireotide (0803043Q0)
Tamoxifen Citrate (0803041S0)
Toremifene Citrate (0803041U0)
Triptorelin (Acetate) (0803042P0)
Triptorelin Embonate (0803042S0)